3 Sep 2008

Vimpat® Approved in Europe

Read More
28 Aug 2008

UCB launches SHAPE, focusing on its Biopharma specialist efforts, and intends to reduce its world-wide workforce

Read More
1 Aug 2008

UCB reports financials in line with expectations, integration completed, R&D milestones achieved and stronger focus on core business

Read More
29 Jul 2008

UCB receives not-approvable letter from FDA for lacosamide for diabetic neuropathic pain

Read More
1 Jul 2008

UCB's Cimzia® filed with EMEA for treatment of rheumatoid arthritis

Read More
26 Jun 2008

UCB's Vimpat(TM) recommended for approval in Europe for epilepsy

Read More
24 Jun 2008

First results for Phase IIa data of UCB's lacosamide for treatment of fibromyalgia

Read More
10 Jun 2008

Otsuka and UCB agreed to co-develop and co-promote Keppra® and Cimzia® in Japan

Read More
6 Jun 2008

US FDA grants pediatric exclusivity for UCB's Keppra®

Read More
4 Jun 2008

UCB to implement full cold-chain for Neupro®

Read More
Subscribe to